I think this is the time Novogen will explode higher. They will release trial results from Yale before year end, just when biotechs are booming. Novogen should attract worldwide attention especially from US investment funds. Check out Genentech, mkt cap $41bn and still going strong. For $100per share Novogen only needs a market cap of about 6bn and we know Novogen's Phenoxodiol has:
1) Worked in Phase II ovarian cancer trials ("regression and stabilisation")
2) "skin cancers fell off"
3) Works using the tnox, Cnox pathways (among others) which means that it could well work for ALL cancer. That would be worth much more than Genetech.
If NVGN had DNA's market cap the stock price would be approx $680 per share... not bad considering the stock is only $4.80 with downside protention from all their other products e.g. NV-07a.
I've become a believer in VCR and think they will do very well. But this placement is likely to spook alot of investors/traders who bought in above $3. For the short term anyway.
Cheers,
Munch.
- Forums
- ASX - By Stock
- VCR
- *** going to get smashed ***
VCR
ventracor limited
*** going to get smashed ***, page-26
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online